Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Jones

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
JCI Insight|August 26, 2020
ETV6 germline mutations cause HDAC3/NCOR2 mislocalization and upregulation of interferon response genesMarlie H Fisher, Gregory D Kirkpatrick, Brett Stevens, et al.
The Journal of Trauma and Acute Care Surgery|March 20, 2018
Systemic hyperfibrinolysis after trauma: a pilot study of targeted proteomic analysis of superposed mechanisms in patient plasmaAnirban Banerjee, Christopher C Silliman, Ernest E Moore, et al.
Shock (Augusta, Ga.)|November 15, 2022
TRAUMA INDUCES INTRAVASCULAR HEMOLYSIS, EXACERBATED BY RED BLOOD CELL TRANSFUSION AND ASSOCIATED WITH DISRUPTED ARGININE-NITRIC OXIDE METABOLISMTerry R Schaid, Mitchell J Cohen, Angelo D'Alessandro, et al.
Journal of Virology|July 28, 2017
Targeted Genome Sequencing Reveals Varicella-Zoster Virus Open Reading Frame 12 DeletionRandall J Cohrs, Katherine S Lee, Addilynn Beach, et al.
Developmental Cell|May 2, 2017
Multi-site Neurogenin3 Phosphorylation Controls Pancreatic Endocrine DifferentiationRoberta Azzarelli, Christopher Hurley, Magdalena K Sznurkowska, et al.
The Journal of Trauma and Acute Care Surgery|February 2, 2023
A proteomic analysis of NETosis in trauma: Emergence of serpinB1 as a key playerTerry R Schaid, Ian LaCroix, Kirk C Hansen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2018
Resistance Mechanisms to Targeted Therapies in <i>ROS1</i><sup>+</sup> and <i>ALK</i><sup>+</sup> Non-small Cell Lung CancerCaroline E McCoach, Anh T Le, Katherine Gowan, et al.
JCI Insight|June 9, 2016
Deficiency of mitochondrial modulator MCJ promotes chemoresistance in breast cancerMaria J Fernández-Cabezudo, Issam Faour, Kenneth Jones, et al.
Blood|July 18, 2019
TNF-α-driven inflammation and mitochondrial dysfunction define the platelet hyperreactivity of agingPavel Davizon-Castillo, Brandon McMahon, Sonia Aguila, et al.
Blood|December 22, 2021
Overcoming IMiD resistance in T-cell lymphomas through potent degradation of ZFP91 and IKZF1Wenchao Wu, Geoffrey M Nelson, Raphael Koch, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
JCI Insight|August 26, 2020
ETV6 germline mutations cause HDAC3/NCOR2 mislocalization and upregulation of interferon response genesMarlie H Fisher, Gregory D Kirkpatrick, Brett Stevens, et al.
The Journal of Trauma and Acute Care Surgery|March 20, 2018
Systemic hyperfibrinolysis after trauma: a pilot study of targeted proteomic analysis of superposed mechanisms in patient plasmaAnirban Banerjee, Christopher C Silliman, Ernest E Moore, et al.
Shock (Augusta, Ga.)|November 15, 2022
TRAUMA INDUCES INTRAVASCULAR HEMOLYSIS, EXACERBATED BY RED BLOOD CELL TRANSFUSION AND ASSOCIATED WITH DISRUPTED ARGININE-NITRIC OXIDE METABOLISMTerry R Schaid, Mitchell J Cohen, Angelo D'Alessandro, et al.
Journal of Virology|July 28, 2017
Targeted Genome Sequencing Reveals Varicella-Zoster Virus Open Reading Frame 12 DeletionRandall J Cohrs, Katherine S Lee, Addilynn Beach, et al.
Developmental Cell|May 2, 2017
Multi-site Neurogenin3 Phosphorylation Controls Pancreatic Endocrine DifferentiationRoberta Azzarelli, Christopher Hurley, Magdalena K Sznurkowska, et al.
The Journal of Trauma and Acute Care Surgery|February 2, 2023
A proteomic analysis of NETosis in trauma: Emergence of serpinB1 as a key playerTerry R Schaid, Ian LaCroix, Kirk C Hansen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2018
Resistance Mechanisms to Targeted Therapies in <i>ROS1</i><sup>+</sup> and <i>ALK</i><sup>+</sup> Non-small Cell Lung CancerCaroline E McCoach, Anh T Le, Katherine Gowan, et al.
JCI Insight|June 9, 2016
Deficiency of mitochondrial modulator MCJ promotes chemoresistance in breast cancerMaria J Fernández-Cabezudo, Issam Faour, Kenneth Jones, et al.
Blood|July 18, 2019
TNF-α-driven inflammation and mitochondrial dysfunction define the platelet hyperreactivity of agingPavel Davizon-Castillo, Brandon McMahon, Sonia Aguila, et al.
Blood|December 22, 2021
Overcoming IMiD resistance in T-cell lymphomas through potent degradation of ZFP91 and IKZF1Wenchao Wu, Geoffrey M Nelson, Raphael Koch, et al.
Pageof 9